← Leaderboards
Charles Sanchez
Fundacion Inciensa
$787,124
Attributed
$787,124
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $295.8K · FY2019–22$500K$375K$250K$125K$0
'19
'20
'21
'22
Funding mix
By agency
NIH$787,124 · 1
By mechanism
N01$787,124 · 1
Top collaborators
No co-investigators on record.
Most similar at Fundacion Inciensa
Same institution · by research overlap
- Paula Gonzalez-Maya$38,145,031
- Carolina Porras$11,742,990
- Rolando Herrero$14,003,389
- Paula Gonzalez$28,686,384
- Ana Cecilia Rodriguez$4,601,397
Others in their field
Other Emerging Leaders on “Institutes”
- Leonard Freedman · Leidos Biomedical Research, Inc.$835,530,754
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$315,119,676
- Lynn Briscoe · Leidos Biomedical Research, Inc.$301,696,350
Research focus
InstitutesParticipantAntibodiesHuman Papilloma Virus VaccineLaboratoriesMonitorBiologicalClinical TrialsComplementBiological TestingBlood SpecimenData Collection12 Year OldMalignant NeoplasmsDoseElectronic DataEnrollmentEnsureFollow-UpFollow-Up StudiesGirlsHuman Papillomavirus 16Costa RicaPerformance
Grant awards (4)
FOLLOW-UP OF PARTICIPANTS ENROLLED IN THE PRIMAVERA-ESCUDDO TRIAL$156,802
N01 · FY2022 · CA · contact PI
FOLLOW-UP OF PARTICIPANTS ENROLLED IN THE PRIMAVERA-ESCUDDO TRIAL$295,832
N01 · FY2021 · CA · contact PI
FOLLOW-UP OF PARTICIPANTS ENROLLED IN THE PRIMAVERA-ESCUDDO TRIAL$261,393
N01 · FY2020 · CA · contact PI
FOLLOW-UP OF PARTICIPANTS ENROLLED IN THE PRIMAVERA-ESCUDDO TRIAL$73,097
N01 · FY2019 · CA · contact PI